2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritisJasvinder A. Singh, Kenneth G. Saag, Claire Bombardier et al.|Arthritis Care & Research|2012Cited by 1.8k
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1Lauren A. Henderson, Jay Mehta, Scott Canna et al.|Arthritis & Rheumatology|2020Cited by 537
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 2Lauren A. Henderson, Jay Mehta, Scott Canna et al.|Arthritis & Rheumatology|2020Cited by 415
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 3Lauren A. Henderson, Jay Mehta, Kevin G. Friedman et al.|Arthritis & Rheumatology|2022Cited by 297
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3Ted R. Mikuls, Kenneth G. Saag, Sindhu R. Johnson et al.|Arthritis & Rheumatology|2020Cited by 242